Upstate Active Clinical Trials
Study Title:Bayer Protocol 13024: A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of on-demand and prophylactic treatment with BAY 94-9027 in Severe Hemophilia A
Upstate Institutional Review Board (IRB) Number:357407
Study Phase:II, III
Patient Age Group:Adults
Principal Investigator:Thomas E Coyle, MD
Who can I contact for more information?
Name: Diane M Gould